Principal Financial Group’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,738
Closed -$99.5K 2414
2024
Q1
$99.5K Sell
10,738
-110
-1% -$1.29K ﹤0.01% 2279
2023
Q4
$138K Buy
10,848
+67
+0.6% +$698 ﹤0.01% 2223
2023
Q3
$111K Sell
10,781
-468
-4% -$5.42K ﹤0.01% 2268
2023
Q2
$147K Buy
+11,249
New +$138K ﹤0.01% 2225
2023
Q1
Sell
-10,450
Closed -$88.1K 2484
2022
Q4
$88.1K Buy
+10,450
New +$99.4K ﹤0.01% 2315
2022
Q1
Sell
-16,486
Closed -$529K 2582
2021
Q4
$529K Buy
16,486
+9,394
+132% +$343K ﹤0.01% 2109
2021
Q3
$255K Sell
7,092
-1,147
-14% -$45.1K ﹤0.01% 2355
2021
Q2
$364K Buy
+8,239
New +$359K ﹤0.01% 2291

Other funds holding LUNG

Principal Financial Group's LUNG Position: Q2 2024 in Review

Principal Financial Group sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 10,738 shares — an estimated $99.5K sold.

Principal Financial Group first reported a position in LUNG in Q2 2021 and held it in 8 quarters. The position peaked at $529K in Q4 2021. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Principal Financial Group reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 10,738 Pulmonx shares in Q2 2024, an estimated $99.5K.
  • Principal Financial Group first reported a position in Pulmonx in Q2 2021 and held it in 8 quarters.
  • Principal Financial Group's Pulmonx position peaked at $529K in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.